Common use

Trecator-SC (ethionamide) is a second-line anti-tuberculosis medication with a bacteriostatic mechanism of action. It works by suppressing bacterial protein synthesis, effectively inhibiting the growth and reproduction of Mycobacterium tuberculosis at both intracellular and extracellular locations. When you buy Trecator-SC online, you receive a medication that plays a crucial role in the treatment of tuberculosis, particularly in cases where first-line TB drugs have proven insufficient or when multidrug-resistant TB has been diagnosed.

As an anti-TB medication, ethionamide enhances phagocytosis at the center of tuberculosis inflammation, which facilitates the resolution of tuberculous lesions and supports the body's immune response against mycobacterial infection. This makes Trecator-SC an essential component of multi-drug treatment regimens for tuberculosis.

Beyond tuberculosis treatment, Trecator-SC may also be used in the management of Leprosy (Hansen's disease), providing an additional therapeutic option for this chronic mycobacterial infection. As a second-line TB treatment, ethionamide is most commonly prescribed as part of combination therapy alongside other anti-tuberculosis agents to prevent the development of drug resistance and maximize treatment effectiveness. Trecator generic is available for patients who need affordable access to this important TB drug.



Dosage and directions

Your individual dose of Trecator-SC depends on your specific condition, age, body weight, and overall health status, and must be determined by your doctor. The typical adult dose of ethionamide ranges from 500 mg to 1000 mg daily, usually divided into multiple doses throughout the day.

Take each dose with a large glass of water. Trecator-SC can be taken with or without food; however, taking this anti-TB medication with food or a light snack may significantly help reduce gastrointestinal upset, which is one of the most common side effects of ethionamide therapy.

It is critically important to continue your tuberculosis treatment for the entire prescribed duration — even if your symptoms have disappeared and you feel well. TB bacteria can remain dormant in the body, and stopping this TB drug too early may lead to treatment failure or the emergence of multidrug-resistant TB, which is far more difficult and expensive to treat. Only discontinue Trecator-SC upon direct recommendation from your treating physician.



Precautions

Before starting ethionamide therapy, provide your doctor with a complete list of all prescription medications, over-the-counter drugs, vitamins, and herbal products you are currently taking. Inform your healthcare provider about any known allergies, whether you are pregnant, planning to become pregnant, or breastfeeding.

Regular monitoring of liver function tests is essential during treatment with Trecator-SC, as ethionamide can cause hepatotoxicity. Blood glucose levels should also be checked periodically, especially in patients with diabetes. Eye examinations may be recommended during prolonged tuberculosis treatment, as visual disturbances have been reported with this anti-TB medication.

Avoid consuming alcohol while taking Trecator-SC, as it may increase the risk of liver damage and worsen side effects such as nausea and psychotic reactions. Patients should report any signs of depression, mood changes, or unusual behavior to their doctor immediately.



Contraindications

Trecator-SC is contraindicated in patients with severe hepatic impairment, as ethionamide is metabolized by the liver and can cause further liver damage. This anti-tuberculosis medication must not be used by patients who are hypersensitive to ethionamide or any inactive ingredients in the formulation. Pregnant women should not take this TB drug due to potential risks to fetal development.

Special caution is required when prescribing Trecator-SC for patients with diabetes mellitus, as ethionamide may affect blood sugar control and require adjustment of diabetic medications. Patients with epilepsy or a history of seizure disorders should be closely monitored, as this tuberculosis treatment may lower the seizure threshold. Patients with thyroid conditions should also be monitored, as ethionamide may cause hypothyroidism with prolonged use.



Possible side effect

Allergic reactions to Trecator-SC may manifest as hives, skin rash, or swelling of the tongue and face. Seek immediate medical attention if you experience signs of a severe allergic reaction.

Common side effects of ethionamide include gastrointestinal symptoms such as nausea, vomiting, diarrhea, abdominal pain, excessive gas, loss of appetite, and metallic taste in the mouth. Stomatitis (mouth sores) may also occur during treatment with this anti-TB medication.

More serious side effects that require prompt medical attention include: jaundice (yellowing of skin or eyes, indicating possible liver damage), peripheral neuritis (numbness, tingling, burning, or pain in the hands and feet), confusion, mental depression, clumsiness or unsteadiness, visual disturbances, disorders of the menstrual cycle, and impotence. Hepatitis is a potentially serious complication of ethionamide therapy.

If you experience severe or persistent side effects while taking this tuberculosis treatment, notify your doctor immediately, as you may need urgent medical evaluation and possible dose adjustment or discontinuation of the TB drug.



Drug interaction

Significant interactions may occur between Trecator-SC, cycloserine, and isoniazid — co-administration of these anti-tuberculosis medications requires careful monitoring for neurotoxic effects. The drowsiness-inducing effect of ethionamide is aggravated by concurrent use of sedatives, tranquilizers, sleeping pills, narcotic pain relievers, psychiatric medications (such as chlorpromazine), certain antidepressants (such as amitriptyline), certain antihistamines (such as diphenhydramine), muscle relaxants, and anti-seizure medications.

These interactions are especially concerning in patients with a history of neurological or psychiatric disorders. Co-administration with other anti-TB medications may increase the risk of seizures, and this risk should be carefully evaluated by your treating physician.

Inform your doctor about all medications you are taking before starting Trecator-SC therapy, as ethionamide may interact with diabetes medications, anticoagulants, and other drugs metabolized by the liver.



Missed dose

If you miss a dose of Trecator-SC, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and return to your regular dosing schedule. Never take a double dose of this anti-tuberculosis medication to compensate for a missed one, as this increases the risk of side effects without improving treatment efficacy. Consistent adherence to your prescribed TB treatment schedule is essential for successful tuberculosis eradication.



Overdose

Specific symptoms of Trecator-SC overdose are not well documented. If you suspect that you have exceeded the prescribed dosage of ethionamide, seek immediate medical attention. Contact your local poison control center or proceed to the nearest emergency room. Provide healthcare professionals with information about the amount of this TB drug consumed and the time of ingestion to facilitate appropriate treatment.



Storage

Store Trecator-SC at room temperature between 59-77°F (15-25°C) in a dry location away from direct light and moisture. Keep this anti-tuberculosis medication out of reach of children and pets. Do not use ethionamide tablets past their expiration date. Dispose of unused or expired medication properly according to local pharmaceutical waste guidelines.



Disclaimer

We provide only general information about medications which does not cover all directions, possible drug interactions, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.